Phenolic Profile and Cholinesterase, Tyrosinase, Urease and Lipid Peroxidation Inhibition Potentials of Artemisia argyi from Ordu, Turkey
Celal Bayar University Journal of Science
Volume 15, Issue 1, 2019, p 29-33
Doi: 10.18466/cbayarfbe.430835
M. Çol Ayvaz
Phenolic Profile and Cholinesterase, Tyrosinase, Urease and Lipid
Peroxidation Inhibition Potentials of Artemisia argyi from Ordu, Turkey
Melek Çol Ayvaz*
Department of Chemistry, Faculty of Science & Arts, Ordu University, 52200 Ordu, Turkey.
*
Received: 05 June 2018
Accepted: 18 January 2019
DOI: 10.18466/cbayarfbe.430835
Abstract
The present study was designed to reveal a natural resource that could cure for today’s major diseases
such as Alzheimer, Parkinson and bacterial infection. Furthermore, oxidative stress resulting from lipid
peroxidation is a precursor for many diseases. Therefore, anticholinesterase, antityrosinase, antiurease
activities and the inhibition potential on lipid peroxidation of methanolic extract of Artemisia argyi
collected from Ordu region were tested. The inhibition ratio of extract at 0.3 mg/mL concentration for
asetylcholinesterase and butrylcholinesterase were calculated as 8.45 and 10.68%, respectively.
IC50 values for tyrosinase and urease inhibition properties were also found as 0.505 mg/mL and
0.225 mg/mL. The all obtained values were compared with known corresponding inhibitors such as
galantamine, kojic acid and thiourea. Besides these, 0.1 mg/mL of the extract prevented lipid
peroxidation in the ratio of 7.19%. In the scope of this study, the phenolics of the leaves of A. argyi were
also analyzed by using HPLC system and pyrogallol was identified as the major component with the
30.16 mg/kg concentration. On the other hand, benzoic acid was not detected in extract. According to
obtained results, A. argyi from Ordu, has the proposed characteristics that it can be a natural resource that
can be used in the field of medicine for treatment of various diseases especially Alzheimer and Parkinson,
in the cosmetic industry for the elimination of skin problems and in the agricultural field in order to
prevent the loss of nitrogenous components.
Keywords: Artemisia argyi, Helicobacter pylori, enzyme inhibition, melanogenesis, phenolics,
One of the abnormal conditions is that the
overexpression of the enzyme. In similar cases,
restricting the enzyme activity by enzyme inhibitors
which are molecules that have pharmacological effects
thanks to their inhibition character on particular
enzymes is the best approach for treatment. A great
source of bioactive molecules with medicinal value to
treat many diseases thanks to their inhibition potentials
on several enzymes are hidden in nature. So studying
and development of enzyme inhibitors is one way to
find new drugs.
1. Introduction
The Artemisia species, the largest and most widely
distributed genus from Anthemideae tribe of the
Asteraceae family, have more than 500 taxa. Artemisia
species are considered as important medicines
throughout the world thanks to their phytochemical
content depending on chemical and biological
properties. Antitumor, anticancer, antidiabetic, antiinflammatory,
antimutagenic,
antimalarial,
antihypertensive,
anti-histaminic,
antibacterial,
antioxidant, antiviral and anticoagulant/antiplatelet
effects of Artemisia species can be considered as health
benefits [1]. However, these features vary between
different Artemisia species. In addition, environmental
factors play a significant role in growth as well as the
content of active compounds responsible for these
activities. Artemisia argyi, one of the most well-known
species, is a herbaceous perennial plant of Compositae
artemisia distributing throughout China and used widely
as a traditional Chinese medicine [2].
Alzheimer disease (AD) is a major health problem due
to its severe, chronic and progressive neurodegenerative
character. Especially in developed countries, it is the
majority of deaths among the elder population. Despite
being known for more than hundred years, treatment
strategies of AD are still limited. Among the various
treatment methods, the most preferred one is the
inhibition
of
hydrolysis
of
cholinergic
neurotransmitters, acetylcholine and butrylcholine, by
cholinesterase inhibitors [3].
Because of abnormal functioning of enzymes causes
communicable and metabolic human diseases, enzymes
are regarded as drug targets. In this way, these kind of
diseases can be treated by regulating enzyme activity.
Tyrosinase has an important role in initial step of
melanin biosynthesis. Although, melanin plays an
important role in protecting the skin, overproduction of
29
Celal Bayar University Journal of Science
Volume 15, Issue 1, 2019, p 29-33
Doi: 10.18466/cbayarfbe.430835
M. Çol Ayvaz
it can lead to a variety of dermatological disorders
including skin cancer. Moreover, recent investigations
exhibited the link between many melanogenesis
disorders and neurodegenerative diseases, including
Parkinson's, Alzheimer's and Huntington's diseases.
Because tyrosinase may play a role in the human brain
for neuromelanin formation. Therefore, to prevent the
development of said diseases, inhibition of
melanogenesis is one of the most important
requirements. So, the clinical need continues for
melanogenesis-inhibiting agents.
Using of drugs
targeting tyrosinase for treating melanogenesis is a
classical approach, but many of these have various
unwanted side effects [4-6].
According to report of Melguizo-Melguizo et al., [11]
despite the essential oil of this plant has been widely
studied, the polar fraction which contains mainly
phenolic compounds responsible for their biological
activity and health benefits has been less searched. In
this context, the phenolic component of which we
thought might be responsible for said inhibitory
potencies of the plant was also investigated.
When the literature is carefully examined, it is
noteworthy that most studies on enzyme inhibition
potentials of Artemisia species concentrate on species
other than A. argyi. Furthermore, the lack of the studies
on Artemisa species from Turkey, led us to this
research. This study ensures an overview on the
inhibition potentials of A. argyi on many crucial enzyme
activities and lipid peroxidation. Besides these, phenolic
profile of the obtained sample was scanned to get
information about the phenolics of the methanolic
extract. Thus, it was aimed that to contribute to the
fields of pharmacology, medicine, cosmetics and
agriculture in the direction of the results obtained.
Urease which is a key enzyme for nitrogen cycle
catalyses the hydrolysis of urea in to CO2 and NH3.
Urease has a role in the colonization of Helicobacter
pylori in gastric epithelium by adjusting the stomach
pH. However, the bacterial infection causes many
diseases such as inflammation, pyelonephritis, ulcers
and adenocarcinoma. Such diseases can be treated with
antibiotic use. However, the increasing resistance of
bacteria towards antibiotics requires new approaches in
this area. Therefore, inhibition of urease activity is
effective on the treatment of H. pylori relat (...truncated)